Mild Alzheimer's Disease research hub

Evaluation of the Safety and Efficacy of NeuroEPO in Subjects With Mild to Moderate Alzheimer's Disease

This study is testing a new medicine, NeuroEPO, for people with mild to moderate Alzheimer's disease. Researchers want to see if it helps brains work better or stops them getting worse over a year. They also want to check for any side effects. Half the people will get NeuroEPO, and half will get a dummy medicine.